Abbott Laboratories is recalling 816 Alinity hq Analyzers due to a software defect that can cause inaccurate blood test results. When specific types of blood tests are run back-to-back, the device may report falsely low red blood cell counts, falsely low hematocrit, and falsely high hemoglobin measurements. Additionally, the analyzer may incorrectly count cell events as basophils, leading to inaccurate white blood cell differentials. These errors could lead to incorrect medical diagnoses or inappropriate treatment for patients.
The software defect causes the analyzer to provide incorrect data for critical blood parameters like red blood cell counts and basophil levels. This creates a risk of medical mismanagement, where a patient might receive unnecessary treatment or have a serious condition go undetected based on the faulty lab results.
Software update and usage protocol adjustment
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.